RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Phone386-418-8888
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$279.56 million
Profitability
Miscellaneous
Employees942
OptionableOptionable
RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions
What is RTI Surgical's stock symbol?
RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."
How were RTI Surgical's earnings last quarter?
RTI Surgical Inc (NASDAQ:RTIX) posted its earnings results on Thursday, November, 1st. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.01 by $0.02. The medical equipment provider had revenue of $69.06 million for the quarter, compared to analysts' expectations of $70.09 million. RTI Surgical had a positive return on equity of 4.04% and a negative net margin of 3.91%. View RTI Surgical's Earnings History.
When is RTI Surgical's next earnings date?
What guidance has RTI Surgical issued on next quarter's earnings?
RTI Surgical updated its FY 2018 earnings guidance on Thursday, November, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $280-280 million, compared to the consensus revenue estimate of $283.5 million.
What is the consensus analysts' recommendation for RTI Surgical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RTI Surgical.
Has RTI Surgical been receiving favorable news coverage?
Media stories about RTIX stock have been trending somewhat positive on Saturday, InfoTrie reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. RTI Surgical earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the company's share price in the next few days.
Who are some of RTI Surgical's key competitors?
Some companies that are related to RTI Surgical include Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Bionik Laboratories (BNKL), COLLPLANT HOLDI/S (CLGN), NanoVibronix (NAOV), Precision Therapeutics (AIPT), Histogenics (HSGX), Wound Management Technologies (WNDM), Rewalk Robotics (RWLK), Allied Healthcare Products (AHPI), Avitar (AVTI) and Halyard Health (HYH).
Who are RTI Surgical's key executives?
RTI Surgical's management team includes the folowing people:
- Mr. Camille I. Farhat, CEO, Pres & Director (Age 49)
- Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 55)
- Mr. John N. Varela, Exec. VP of Global Operations (Age 52)
- Mr. Johannes Wynand Louw, VP of Financial Planning & Analysis
- Mr. Olivier Visa, VP of OEM, Sports & Donor Services (Age 50)
How do I buy shares of RTI Surgical?
Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is RTI Surgical's stock price today?
One share of RTIX stock can currently be purchased for approximately $4.29.
How big of a company is RTI Surgical?
RTI Surgical has a market capitalization of $274.15 million and generates $279.56 million in revenue each year. The medical equipment provider earns $6.27 million in net income (profit) each year or $0.05 on an earnings per share basis. RTI Surgical employs 942 workers across the globe.
What is RTI Surgical's official website?
How can I contact RTI Surgical?
RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]
MarketBeat Community Rating for RTI Surgical (NASDAQ RTIX)
MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
